IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 127 filers reported holding IMMUNOCORE HLDGS PLC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.6%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $29,942,304 | 35.70% |
| RTW INVESTMENTS, LP | 6,096,387 | $316,402,485 | 6.68% |
| Paradigm Biocapital Advisors LP | 1,384,686 | $71,865,203 | 4.88% |
| Rock Springs Capital Management LP | 2,943,710 | $152,778,549 | 4.09% |
| Logos Global Management LP | 450,000 | $23,355,000 | 3.12% |
| TANG CAPITAL MANAGEMENT LLC | 405,600 | $21,050,640 | 2.97% |
| GREAT POINT PARTNERS LLC | 290,917 | $15,098,592 | 2.75% |
| Nicholas Investment Partners, LP | 512,855 | $26,617,175 | 1.99% |
| Eschler Asset Management LLP | 30,000 | $1,557,000 | 1.82% |
| COWEN AND COMPANY, LLC | 460,036 | $23,875,868 | 1.67% |
| BRAIDWELL LP | 906,973 | $47,071,899 | 1.49% |
| Samsara BioCapital, LLC | 80,963 | $4,201,980 | 1.29% |
| HighVista Strategies LLC | 39,804 | $2,065,828 | 0.96% |
| GENERAL ATLANTIC, L.P. | 950,000 | $49,305,000 | 0.76% |
| Baker Brothers Advisors | 2,520,731 | $130,825,939 | 0.75% |
| Pier Capital, LLC | 87,422 | $4,537,202 | 0.73% |
| Avidity Partners Management LP | 348,200 | $18,071,580 | 0.73% |
| Rhenman & Partners Asset Management AB | 89,278 | $4,633,528 | 0.50% |
| Dalton Investments LLC | 10,000 | $519,000 | 0.40% |
| ARMISTICE CAPITAL, LLC | 400,000 | $20,760,000 | 0.32% |
External links
This page lists IMMUNOCORE HLDGS PLC's shareholders in Q3 2023. To view IMMUNOCORE HLDGS PLC's shareholder history, click here.